Clinical Study
Treatment of Rhinitis Sicca Anterior with Ectoine Containing Nasal Spray
Table 3
Patients’ assessments of secondary symptom scores at days 3, 6, 9, and 12 following treatment start of study 1.
| Symptoms | d3 | d6 | d9 | d12 | value (d3 versus d12) |
| Nose bleeding | 0.36 ± 0.85 | 0.46 ± 1.07 | 0.36 ± 0.85 | 0.30 ± 0.74 | 0.787 | Pharyngitis | 0.64 ± 1.77 | 0.62 ± 1.74 | 0.46 ± 1.20 | 0.42 ± 1.13 | 0.754 | Exudate viscosity | 3.36 ± 3.50 | 2.90 ± 3.03 | 2.38 ± 2.86 | 2.40 ± 2.93 | 0.108 | Rhinorrhea | 2.44 ± 2.16 | 2.10 ± 2.14 | 1.74 ± 1.88 | 1.42 ± 1.54 | 0.021 | Cacosmia | 0.60 ± 1.53 | 0.48 ± 1.31 | 0.42 ± 1.57 | 0.26 ± 0.69 | 0.388 |
|
|